The nitric oxide hypothesis of migraine and other vascular headaches.
about
Current Understanding on Pain Mechanism in Migraine and Cluster HeadacheIncrease in meningeal blood flow by nitric oxide--interaction with calcitonin gene-related peptide receptor and prostaglandin synthesis inhibitionCGRP may play a causative role in migraineNeuronal signal substances as biomarkers of migrainePatients with migraine with aura have increased flow mediated dilation.Diencephalic and brainstem mechanisms in migraine.Genetics of migraine without aura, migraine with aura, migrainous disorder, head trauma migraine without aura and tension-type headache.Human migraine models.Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks.Distribution of artemin and GFRalpha3 labeled nerve fibers in the dura mater of rat: artemin and GFRalpha3 in the dura.Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment.Association of the Apolipoprotein E polymorphism with migraine: a meta-analysis.Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine.Can we develop neurally acting drugs for the treatment of migraine?Polymorphism in apolipoprotein E among migraineurs and tension-type headache subjects.Response properties of dural nociceptors in relation to headache.Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the ratMigraine: emerging treatment options for preventive and acute attack therapy.Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women studyNitric oxide-related drug targets in headache.Migraine is a neuronal disease.CGRP and NO in the trigeminal system: mechanisms and role in headache generation.Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience.Pearls and pitfalls in experimental in vivo models of headache: conscious behavioral research.L-arginine and nitric oxide in CNS function and neurodegenerative diseases.Breath powered nasal delivery: a new route to rapid headache relief.Histamine in migraine and brain.Drugs targeting nitric oxide synthase for migraine treatment.Cerebral hemodynamics in the different phases of migraine and cluster headache.High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients.Pathophysiology of Migraine: A Disorder of Sensory Processing.Sumatriptan scavenges superoxide, hydroxyl, and nitric oxide radicals: in vitro electron spin resonance study.Migraine can be induced by sildenafil without changes in middle cerebral artery diameter.Headache induced by serotonergic agonists--a key to the interpretation of migraine pathogenesis?Recognizing exercise-related headache.The KATP channel in migraine pathophysiology: a novel therapeutic target for migraine.Lack of association between urotensin-II (UTS2) gene polymorphisms (Thr21Met and Ser89Asn) and migraine.Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache.The calcitonin gene-related peptide receptor antagonist MK-8825 decreases spinal trigeminal activity during nitroglycerin infusion.Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels
P2860
Q28079173-A89F5AA8-6B28-4372-ADF9-4B7010BD9D94Q28193135-2578425A-D207-4FFD-ADE3-0BB1FCF3A4F0Q28216666-0D1DC899-E545-434B-93FB-C1283140B756Q28254002-F41B93EA-7798-4BF7-8BDD-A3B992530249Q33539437-EA0F6AAB-4CF8-47BF-A9E8-50B467EAA851Q34217686-1205614A-E924-42E4-B9A3-000095F62883Q34397689-BB2A91B0-46FE-404A-A1AE-DDD84F66C9EFQ34397694-B321A639-0762-4707-ACA0-9E3EB8A9A826Q34469372-A3D6165C-C9E6-4EA9-9FF0-02D79BB979EDQ34782038-9A17A3AF-DF17-4757-9403-1DB486D72C43Q34978115-03D6F031-BF3B-4097-9817-14FAA23A7D42Q35743126-60726555-BFCE-47B4-B076-CCE8EC103661Q35952529-21F504F1-E14B-4C80-9163-EBA7CA7A9BADQ36240187-1F6B185D-B907-46DC-B5F5-72834332E973Q36259580-BDA7B416-C679-44E2-A475-1AC0F48239E0Q36403060-5F96FDC3-8409-458B-9E8D-8B831803E396Q36535390-7ED69079-1DA9-4A10-9446-65EADF3ECABFQ36580576-352AF314-42F0-4E2E-B45C-1E5B77A0ABB4Q37366628-478EE05C-1812-46E4-91F0-39D801E8AC35Q37739589-F43CD588-79D5-4D30-B7D2-069F7EB172A6Q37821333-E34D9842-D85E-4C6B-A9B6-03AB970220D7Q38025661-7A11692A-5D43-4249-B026-511E2489B41BQ38106681-7B983835-F5DD-4F82-AB37-5FC5A75281ACQ38106684-9D2C228E-5C49-40B5-BE08-7CA9CFB9845FQ38134415-15E84C87-182D-4171-A4D5-A63DADA50B41Q38136260-89C690B4-1771-443F-AF2F-D0C82E3C5CC9Q38179055-CD5AA297-4258-4EFD-BA1B-4EB35EC1212DQ38211063-49C6EA42-23D6-47BA-9AD5-FF0F50E67597Q38635129-18448D0F-F505-40FA-9502-8E01E8086AFFQ38813271-CFC700D1-E726-4211-9AC8-8343EA53248CQ39127073-666687A7-4E2B-46C9-AEBD-2FB808B7AFD6Q39401924-6ED5038E-1C51-42FD-BFAB-5E592C594F75Q40616175-76648ADD-84C2-462E-8219-56BBAE210D3EQ41364582-3D5E244C-7324-49EF-8149-187D98A49FD2Q41488976-7F48A074-4C46-4162-9093-252D22BD8F68Q41492299-9A5A78EF-8FB3-4546-82D1-FB97029B3708Q41598178-8D0CA840-8CDA-4C44-816F-9560E997CF2FQ41695528-E2BAD7E6-A0E0-4FE2-8997-610884ACD468Q41829270-B89AB767-809A-4369-B985-CC4847ECA11EQ42186934-CF3EB680-46AA-4CFC-ABEB-36AA9D2E3E11
P2860
The nitric oxide hypothesis of migraine and other vascular headaches.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The nitric oxide hypothesis of migraine and other vascular headaches.
@en
type
label
The nitric oxide hypothesis of migraine and other vascular headaches.
@en
prefLabel
The nitric oxide hypothesis of migraine and other vascular headaches.
@en
P2093
P2860
P1433
P1476
The nitric oxide hypothesis of migraine and other vascular headaches.
@en
P2093
I J Olesen
L H Lassen
L L Thomsen
P2860
P304
P356
10.1046/J.1468-2982.1995.015002094.X
P407
P50
P577
1995-04-01T00:00:00Z